Starpharma Holdings LtdShs Aktie
0,06EUR | 0,00EUR | -2,56% |
WKN: 796461 / ISIN: AU000000SPL0
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 93,93 |
Allianz Global Investors Asia Pacific Ltd. | 11,60 |
Allianz Global Investors Fund - Oriental Income | 8,42 |
ICM Investment Management Ltd. | 5,11 |
Allan Gray Australia Pty Ltd. | 4,98 |
FIL Investment Advisors (UK) Ltd. | 4,85 |
M&G Investment Management Ltd. | 4,34 |
Fidelity Funds SICAV - Pacific Fund | 2,86 |
Mirrabooka Investments Ltd. | 2,08 |
T&N Argyrides Investments Pty Ltd. | 1,21 |
Government Pension Fund - Global (The) | 1,03 |
Jacinth K. Fairley, PhD, MBA | 0,97 |
Kingsley Bryan Bartholomew | 0,82 |
Applecross Secretarial Services Pty Ltd. | 0,80 |
Vanguard Total International Stock Index Fund | 0,67 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 50 | 50 | 50 | 45 | 40 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,12 | 0,04 | 0,09 | 0,07 | 0,21 |
Bilanz (in Mio. AUD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 37 | 71 | 61 | 47 | 33 |
Summe Anlagevermögen | 2 | 2 | 6 | 5 | 4 |
Summe Aktiva | 39 | 73 | 66 | 52 | 37 |
Bilanz (in Mio. AUD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 8 | 11 | 18 | 17 | 9 |
Summe Eigenkapital | 31 | 62 | 48 | 35 | 28 |
Summe Passiva | 39 | 73 | 66 | 52 | 37 |
Adresse
4-6 Southampton Crescent, 3067 Abbotsford | |
Telefon | +61 (3) 8532-2700 |
Internet | http://www.starpharma.com |
Management
Cheryl Maley
Chief Executive Officer, Director & MD |
David John McIntyre
Independent Non-Executive Director |
Jeff Davies
Independent Non-Executive Director |
Jeremy R. Paull
Vice President-Development & Regulatory Affairs |
Justin Cahill
Chief Financial Officer & Secretary |
Lynda Cheng
Independent Non-Executive Director |
Miranda Sowden
Director-People & Culture |
Robert Bain Thomas
Chairman |
Russell Basser
Independent Non-Executive Director |
Tony Eglezos
Vice President-Business Development |